Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine + dexamethasone for analgesia after robot-assisted mediastinal tumor resection
ChiCTR2600124157Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in mediastinal mass comparing Liposomal bupivacaine arm with Ropivacaine + dexamethasone arm (2 arms). Primary endpoint: Resting NRS pain score at 24 hours postoperatively. Started May 2026; status: recruiting.
02
Drugs
bupivacaineropivacainedexamethasone
03
Conditions
mediastinal mass
Beyond the preview
Go deeper on ChiCTR2600124157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124157.